Navigation Links
New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law
Date:10/14/2009

ARLINGTON, Va., Oct. 14 /PRNewswire-USNewswire/ -- The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law. Published by BNA Books, a division of BNA, Pharmaceutical Patent Law is supplemented annually and provides complete coverage of intricate topics, including the antitrust implications of patent settlements; the experimental use privilege; and international aspects of the field, including comparative data protection laws, the benefits and limitations of the Paris Convention, the Patent Cooperation Treaty, Foreign Filing Licenses, regional agreements, and the TRIPS agreement.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090529/DC24463LOGO )

The 2009 Cumulative Supplement includes the following new information:

  • Legislative developments in the 111th Congress concerning patents, follow-on biologics, and Hatch-Waxman reform
  • The continuing impact of Supreme Court precedent upon pharmaceutical patent law, including the law of obviousness and declaratory judgment jurisdiction
  • The new rules concerning the extension of the Hatch-Waxman Act's 30-month stay of marketing approval
  • Coverage of judicial reaction to concerns over baseless Paragraph IV ANDA filings
  • Updated information on the construction of pharmaceutical patent claims

Pharmaceutical Patent Law not only reviews current issues of importance, but identifies topics such as parallel importation and authorized generics that are likely to be of growing significance. The treatise is invaluable to the busy practitioner who must keep on track in this evolving area of the law. The author, Professor John R. Thomas, is a member of the faculty of Georgetown University Law Center, Washington, DC, where he teaches courses in both patent and food and drug law. A widely published author in the field of pharmaceutical patent law, he frequently serves as a Special Master in patent litigation before the federal courts.

BNA is a leading private publisher of news and information products for professionals in law and business. In addition to Pharmaceutical Patent Law, BNA's Book Division publishes Biotechnology and the Federal Circuit; Drafting Patent License Agreements; Electronic and Software Patents: Law and Practice; Intellectual Property Taxation: Transaction and Litigation Issues; International Patent Litigation: A Country-by-Country Analysis; Patent Infringement Remedies; Patent Law and Practice; Patent Prosecution: Law, Practice, and Procedure; Patent, Trademark, and Copyright Laws; Patent, Trademark, and Copyright Regulations; Patents and the Federal Circuit; Pharmaceutical Patent Law; Harmon on Patents: Black-Letter Law and Commentary; and other titles in legal specialties. The BNA Books website, including an online catalog, can be found at bnabooks.com.

The new 2009 Cumulative Supplement to Pharmaceutical Patent Law may be purchased alone (Order #1824-PRY9/$225.00 plus tax, shipping, and handling) or with the main volume (Order #9824-PRY9/$390.00 plus tax, shipping, and handling) from BNA Books, PO Box 7814, Edison, NJ 08818-7814. Telephone orders: 1-800-960-1220. Fax orders: 1-732-346-1624. For a free BNA Books catalog, call 1-800-960-1220 or send an e-mail request to books@bna.com. A 10% discount is available on print copies of books when ordered from the website at bnabooks.com. (Please note that discounts cannot be combined).

SOURCE BNA Books


'/>"/>
SOURCE BNA Books
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Shares and Corrects Ex-Dividend Trading Date for Common Shares
2. Cumulative radiation exposure shows increased cancer risk for emergency department patients
3. EPA should pursue cumulative risk assessment of phthalates and other chemicals
4. Antioxidant Supplements May Raise Womens Skin Cancer Risk
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
7. Vitamin D Supplements May Lengthen Life
8. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
9. U of M study: Health food supplement may curb addiction of pathological gamblers
10. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
11. Wellcorps International Unveils New Nutritional Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , ... January 20, 2017 , ... "TransFlare 4K Mystique ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
(Date:1/20/2017)... ... , ... “The Land of More and More”: a brilliant story for ... shares the simple and achievable answer. “The Land of More and More” is the ... Church in Angola, Indiana where he works with the children’s ministry department. , ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network ... of their 503A compounding pharmacy located in Ocala, Florida. , Meeting the ... patients throughout the United States for high-quality human anti-aging and wellness compounded ...
(Date:1/19/2017)... Melville, New York (PRWEB) , ... January 19, ... ... state–of-the-art high definition dynamic telemedicine solutions, has recently unveiled impressive transportable capabilities with ... this newly designed product is an extension to RMT technology that delivers HD, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
(Date:1/19/2017)... , Jan. 18, 2017  Magnetic Insight Inc., ... entered into an agreement with inviCRO LLC to ... MPI imaging system based on inviCRO,s VivoQuant™ visualization ... distributed as a complete MPI solution package with ... nanoparticle or cell imaging in vivo. ...
Breaking Medicine Technology: